AINU-Visakhapatnam Achieves Milestone with 100 HOLEP Surgeries

The Asian Institute of Nephrology and Urology (AINU) in Visakhapatnam has successfully completed its 100th Holmium Laser Enucleation of the Prostate (HOLEP) surgery, marking a significant achievement in modern urological care. This milestone was announced in a press release on September 27, 2025. The program has been spearheaded by a team of skilled urologists, including Dr. G. Ravindra Varma, Dr. Amit Saple, and Dr. Sridhar P., who have utilized advanced laser technology and robust infrastructure to improve patient outcomes.

Dr. G. Ravindra Varma emphasized the relevance of HOLEP in addressing the increasing prevalence of prostate enlargement, particularly among older men facing additional health challenges. “With increasing life expectancy, we are seeing a growing number of men affected by prostate enlargement along with co-morbidities such as diabetes, hypertension, and cardiac conditions,” he stated. He also noted that HOLEP offers a safe and effective solution with minimal complications, even for patients with multiple health issues.

Prostate enlargement, medically known as Benign Prostatic Hyperplasia (BPH), is one of the most common health issues confronting men over the age of 50. Traditionally, this condition has been managed through open or conventional surgical methods. However, advancements in laser technology have revolutionized treatment approaches, making procedures like HOLEP increasingly preferred.

Dr. Amit Saple highlighted the evolving surgical landscape, noting that many men often delay seeking treatment despite experiencing troubling symptoms such as frequent urination, weak urine flow, or a feeling of incomplete bladder emptying. He remarked, “These delays can affect quality of life and lead to complications. HOLEP allows us to treat prostates of any size, something conventional surgery could not always achieve. Globally, HOLEP is becoming the first choice, replacing older methods.”

The successful implementation of the HOLEP program at AINU not only reflects the institution’s commitment to employing cutting-edge medical advancements but also demonstrates a proactive approach to addressing men’s health issues. As awareness of BPH and its implications grows, AINU’s achievement may serve as a model for other healthcare facilities looking to enhance their urological services.

In conclusion, the completion of 100 HOLEP surgeries at AINU represents a significant step forward in the treatment of prostate enlargement, offering patients a modern, effective option for managing their health concerns. As laser technology continues to advance, the potential for improved patient outcomes in urology remains promising.